Matthew S Davids, Christine E Ryan, Benjamin L Lampson, Yue Ren, Svitlana Tyekucheva, Stacey M Fernandes, Jennifer L Crombie, Austin I Kim, Matthew Weinstock, Josie Montegaard, Heather A Walker, Claire Greenman, Victoria Patterson, Caron A Jacobson, Ann S LaCasce, Philippe Armand, David C Fisher, Steve Lo, Adam J Olszewski, Jon E Arnason, Inhye E Ahn, Jennifer R Brown
{"title":"勘误:Acalabrutinib、Venetoclax 和 Obinutuzumab 在治疗无效的慢性淋巴细胞白血病高危人群中的 II 期研究。","authors":"Matthew S Davids, Christine E Ryan, Benjamin L Lampson, Yue Ren, Svitlana Tyekucheva, Stacey M Fernandes, Jennifer L Crombie, Austin I Kim, Matthew Weinstock, Josie Montegaard, Heather A Walker, Claire Greenman, Victoria Patterson, Caron A Jacobson, Ann S LaCasce, Philippe Armand, David C Fisher, Steve Lo, Adam J Olszewski, Jon E Arnason, Inhye E Ahn, Jennifer R Brown","doi":"10.1200/JCO-25-00466","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":" ","pages":"1521-1522"},"PeriodicalIF":42.1000,"publicationDate":"2025-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.\",\"authors\":\"Matthew S Davids, Christine E Ryan, Benjamin L Lampson, Yue Ren, Svitlana Tyekucheva, Stacey M Fernandes, Jennifer L Crombie, Austin I Kim, Matthew Weinstock, Josie Montegaard, Heather A Walker, Claire Greenman, Victoria Patterson, Caron A Jacobson, Ann S LaCasce, Philippe Armand, David C Fisher, Steve Lo, Adam J Olszewski, Jon E Arnason, Inhye E Ahn, Jennifer R Brown\",\"doi\":\"10.1200/JCO-25-00466\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":15384,\"journal\":{\"name\":\"Journal of Clinical Oncology\",\"volume\":\" \",\"pages\":\"1521-1522\"},\"PeriodicalIF\":42.1000,\"publicationDate\":\"2025-04-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1200/JCO-25-00466\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/JCO-25-00466","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/18 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.
期刊介绍:
The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.